Axo Longevity
Axo Longevity is a preventive-health membership that combines recurring laboratory testing with personalised insights and an AI health coach.
$5MSeed
ParticipantLV
LifeX Ventures
Activity from announced rounds
Activity in this selectionEurope
LifeX Ventures is an AI and healthcare investment firm whose current portfolio includes Axo Longevity, Integral Privacy Technologies and Konko AI.
Recorded funding activity
Axo combines preventive-health testing with personalized insights. Konko develops patient-communication software, while Integral prepares data for AI use. The firm portfolio is distinct from its separately labeled previous personal investments and unrelated LifeX namesakes.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $16.6M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionCellbricks Therapeutics
Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs
€10MSeed+Non-Dilutive
Role not disclosed